The present invention is directed to cyclopropyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
申请公布号
WO2006039221(A2)
申请公布日期
2006.04.13
申请号
WO2005US34301
申请日期
2005.09.26
申请人
MERCK & CO., INC.;LINDSLEY, CRAIG, W.;WISNOSKI, DAVID, D.;WOLKENBERG, SCOTT, E.
发明人
LINDSLEY, CRAIG, W.;WISNOSKI, DAVID, D.;WOLKENBERG, SCOTT, E.